Targeting DNA topoisomerase II in cancer chemotherapy

被引:1363
|
作者
Nitiss, John L. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Med Pharmacol, Memphis, TN 38105 USA
关键词
DOUBLE-STRAND BREAKS; DEPENDENT PROTEIN-KINASE; ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; END-JOINING PATHWAYS; RECEPTOR-ALPHA GENES; SACCHAROMYCES-CEREVISIAE; COVALENT COMPLEXES; CELL-CYCLE; HOMOLOGOUS RECOMBINATION;
D O I
10.1038/nrc2607
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent molecular studies have expanded the biological contexts in which topoisomerase 11 (TOP2) has crucial functions, including DNA replication, transcription and chromosome segregation. Although the biological functions of TOP2 are important for ensuring genomic integrity, the ability to interfere with TOP2 and generate enzyme-mediated DNA damage is an effective strategy for cancer chemotherapy. The molecular tools that have allowed an understanding of the biological functions of TOP2 are also being applied to understanding the details of drug action. These studies promise refined targeting of TOP2 as an effective anticancer strategy.
引用
收藏
页码:338 / 350
页数:13
相关论文
共 50 条
  • [41] Response: Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
    Pritchard, Kathleen I.
    O'malley, Frances
    Shepherd, Lois
    Levine, Mark N.
    Tu, Dongsheng
    Bramwell, Vivien
    Andrulis, Irene
    Chia, Stephen
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (24) : 1736 - 1737
  • [42] The prognostic value of topoisomerase II-α for chemotherapy response and survival in breast cancer
    Zakhartseva, L.
    Yanovytska, M.
    Zakhartsev, Y.
    Plodienko, M.
    VIRCHOWS ARCHIV, 2019, 475 : S80 - S80
  • [43] AUTOANTIBODY TO DNA TOPOISOMERASE-II IN PRIMARY LIVER-CANCER
    IMAI, H
    FURUTA, K
    LANDBERG, G
    KIYOSAWA, K
    LIU, LF
    TAN, EM
    CLINICAL CANCER RESEARCH, 1995, 1 (04) : 417 - 424
  • [44] Targeting atypical trypanosomatid DNA topoisomerase I
    Balana-Fouce, Rafael
    Redondo, Carmen M.
    Perez-Pertejo, Yolanda
    Diaz-Gonzalez, Rosario
    Reguera, Rosa M.
    DRUG DISCOVERY TODAY, 2006, 11 (15-16) : 733 - 740
  • [46] Differential expression of DNA topoisomerase II and isozymes in human ovarian cancer
    Chien, CH
    Chow, SN
    Yang, CH
    Ng, HT
    Lin, CT
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (06) : 451 - 459
  • [47] XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus
    Ranganathan, Parvathi
    Kashyap, Trinayan
    Yu, Xueyan
    Meng, Xiaomei
    Lai, Tzung-Huei
    McNeil, Betina
    Bhatnagar, Bhavana
    Shacham, Sharon
    Kauffman, Michael
    Dorrance, Adrienne M.
    Blum, William
    Sampath, Deepa
    Landesman, Yosef
    Garzon, Ramiro
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6142 - 6152
  • [48] Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase
    Ehmann, David E.
    Lahiri, Sushmita D.
    CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 76 - 83
  • [49] TUMOR-NECROSIS-FACTOR AND DNA TOPOISOMERASE-II INHIBITORS IN HUMAN OVARIAN-CANCER - POTENTIAL ROLE IN CHEMOTHERAPY
    ALUIGI, MG
    DEBERNARDIS, D
    CIMOLI, G
    OTTOBONI, C
    PARODI, S
    RUSSO, P
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (03) : 461 - 467
  • [50] Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
    Huanli Xu
    Qunying Chen
    Hong Wang
    Pingxiang Xu
    Ru Yuan
    Xiaorong Li
    Lu Bai
    Ming Xue
    Journal of Experimental & Clinical Cancer Research, 35